RFC
IMMU

Russell Frank Company’s Immunomedics Inc IMMU Stock Holding History

Russell Frank Company’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-123,502
Closed -$765K – 3170
2013
Q3 		$765K Sell
123,502
-24,707
-17% -$142K ﹤0.01% 2310
2013
Q2 		$806K Buy
+148,209
New +$487K ﹤0.01% 2151

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Russell Frank Company's IMMU Position: Q4 2013 in Review

Russell Frank Company sold out of Immunomedics Inc (IMMU) in Q4 2013, closing a stake of 123,502 shares — an estimated $765K sold.

Russell Frank Company first reported a position in IMMU in Q2 2013 and held it in 2 quarters. The position peaked at $806K in Q2 2013. 81 funds tracked by Wall St. Rank hold IMMU as of Q4 2013.

  • Russell Frank Company reported no remaining Immunomedics Inc position as of Q4 2013 after selling out during the quarter.
  • Russell Frank Company sold 123,502 Immunomedics Inc shares in Q4 2013, an estimated $765K.
  • Russell Frank Company first reported a position in Immunomedics Inc in Q2 2013 and held it in 2 quarters.
  • Russell Frank Company's Immunomedics Inc position peaked at $806K in Q2 2013.
  • 81 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2013.

Based on Russell Frank Company's 13F filing for Q4 2013, filed 14 Feb 2014.